AR08

DRUG2 trials

Sponsors

Arbor Pharmaceuticals, Inc.

Conditions

ADHDVasomotor Symptoms (VMS)

Phase 2

AR08 for Treatment of ADHD in Children

CompletedNCT01876719

Arbor Pharmaceuticals, Inc.ADHD

Start: 2013-06-30End: 2015-02-28Updated: 2015-12-09

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

TerminatedNCT02049164

Arbor Pharmaceuticals, Inc.Vasomotor Symptoms (VMS)

Start: 2014-01-31End: 2014-05-31Updated: 2015-12-09